212 related articles for article (PubMed ID: 29378735)
1. New onset diabetes after nivolumab treatment.
Capitao R; Bello C; Fonseca R; Saraiva C
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29378735
[TBL] [Abstract][Full Text] [Related]
2. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
[TBL] [Abstract][Full Text] [Related]
3. Variability in clinical presentation of diabetes mellitus during anti-PD-1 immunotherapy.
Bastin M; Mosbah H; Carlier A; Boudifa A; Villemain A; Hartemann A; Andreelli F
Diabetes Metab; 2020 Oct; 46(5):406-407. PubMed ID: 31034979
[No Abstract] [Full Text] [Related]
4. Anti-PD-L1 therapy and the onset of diabetes mellitus with positive pancreatic autoantibodies.
Way J; Drakaki A; Drexler A; Freeby M
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978581
[TBL] [Abstract][Full Text] [Related]
5. New onset autoimmune diabetes mellitus and hypothyroidism secondary to pembrolizumab in a patient with metastatic lung cancer.
Cunha C; Silva E; Vieira AC; Saraiva C; Duarte S
Endocrinol Diabetes Metab Case Rep; 2022 Feb; 2022():. PubMed ID: 35140188
[TBL] [Abstract][Full Text] [Related]
6. Nivolumab-induced type 1 diabetes mellitus as an immune-related adverse event.
Yilmaz M
J Oncol Pharm Pract; 2020 Jan; 26(1):236-239. PubMed ID: 30955467
[TBL] [Abstract][Full Text] [Related]
7. Acute-onset type 1 diabetes mellitus caused by nivolumab in a patient with advanced pulmonary adenocarcinoma.
Kumagai R; Muramatsu A; Nakajima R; Fujii M; Kaino K; Katakura Y; Okumura N; Ohara G; Kagohashi K; Satoh H; Yagyu H
J Diabetes Investig; 2017 Nov; 8(6):798-799. PubMed ID: 29098805
[TBL] [Abstract][Full Text] [Related]
8. Recognizing and responding to hyperglycaemic emergencies.
Kisiel M; Marsons L
Br J Nurs; 2009 Oct 8-21; 18(18):1094-8. PubMed ID: 19966726
[TBL] [Abstract][Full Text] [Related]
9. Nonketotic hyperosmolar coma in a patient with type 1 diabetes-related diabetic nephropathy: case report.
Dogan E; Erkoc R; Sayarlioglu H; Buyukbese A
Adv Ther; 2005; 22(5):429-32. PubMed ID: 16418150
[TBL] [Abstract][Full Text] [Related]
10. Childhood diabetes presenting with hyperosmolar dehydration but without ketoacidosis: a report of three cases.
Kershaw MJ; Newton T; Barrett TG; Berry K; Kirk J
Diabet Med; 2005 May; 22(5):645-7. PubMed ID: 15842523
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycaemic hyperosmolar state: first presentation of type 1 diabetes mellitus in an adolescent with complex medical needs.
Maduemem KE; Adesanya O; Anuruegbe OO; Rafiq A
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33542015
[TBL] [Abstract][Full Text] [Related]
12. Atezolizumab-Induced New Onset Diabetes Mellitus With Ketoacidosis.
Patti R; Malhotra S; Sinha A; Singh P; Marcelin M; Saxena A
Am J Ther; 2018; 25(5):e565-e568. PubMed ID: 28953510
[No Abstract] [Full Text] [Related]
13. New-onset type 1 diabetes mellitus as a delayed immune-related event after discontinuation of nivolumab: A case report.
Seo JH; Lim T; Ham A; Kim YA; Lee M
Medicine (Baltimore); 2022 Sep; 101(35):e30456. PubMed ID: 36107574
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic mucosal melanoma.
Goff CB; Plaxe SC; White W; Dasanu CA
J Oncol Pharm Pract; 2023 Jul; 29(5):1259-1263. PubMed ID: 36734125
[TBL] [Abstract][Full Text] [Related]
15. Diabetic Ketoacidosis as a Delayed Immune-Related Event after Discontinuation of Nivolumab.
Mae S; Kuriyama A; Tachibana H
J Emerg Med; 2021 Mar; 60(3):342-344. PubMed ID: 33097350
[TBL] [Abstract][Full Text] [Related]
16. [Diabetic emergencies : Hypoglycemia, ketoacidotic and hyperglycemic hyperosmolar nonketotic coma].
Kalscheuer H; Serfling G; Schmid S; Lehnert H
Internist (Berl); 2017 Oct; 58(10):1020-1028. PubMed ID: 28849301
[TBL] [Abstract][Full Text] [Related]
17. [Differential diagnosis of coma in diabetes and their therapy].
Sakamoto Y
Nihon Naika Gakkai Zasshi; 1991 Aug; 80(8):1226-31. PubMed ID: 1919240
[No Abstract] [Full Text] [Related]
18. Hyperosmolar non-ketotic diabetic coma as a cause of emergency hyperglycaemic admission to Baragwanath Hospital.
Rolfe M; Ephraim GG; Lincoln DC; Huddle KR
S Afr Med J; 1995 Mar; 85(3):173-6. PubMed ID: 7777971
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of hyperosmolar hyperglycemic nonketotic diabetic coma associated with cardiac operations.
Seki S
J Thorac Cardiovasc Surg; 1986 Jun; 91(6):867-73. PubMed ID: 3520159
[TBL] [Abstract][Full Text] [Related]
20. [Hyperglycemic hyperosmolar nonketotic syndrome].
Reingardiene D
Medicina (Kaunas); 2003; 39(7):707-12; quiz 713-4,717. PubMed ID: 12878827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
